Welcome to our dedicated page for Envista Holdings news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings stock.
Envista Holdings Corp (NVST) delivers innovative dental solutions through implants, orthodontic systems, and digital imaging technologies. This news hub provides investors and dental professionals with essential updates about the company's operational developments and market position.
Track key announcements including quarterly earnings disclosures, new product clearances, strategic partnerships, and leadership updates. Our curated collection ensures access to both regulatory filings and transformative initiatives like AI-enhanced dental workflow advancements.
Discover how Envista's Specialty Products & Technologies and Equipment & Consumables segments evolve through verified press releases. Bookmark this page for real-time insights into one of dentistry's most comprehensive solution providers, serving practitioners across 150+ countries.
Envista Holdings (NYSE: NVST) reported strong Q2 2021 results with sales reaching $740.1 million, a remarkable increase of 104.4% year-over-year. Core sales growth was 102.3%, outpacing pre-pandemic levels by 5.6% compared to Q2 2019. Net income stood at $90.1 million or $0.51 per diluted share, with adjusted EBITDA soaring to $140.4 million. The company’s adjusted EBITDA margin was 19%. Looking ahead, Envista projects full-year sales between $2.8 billion and $2.9 billion and maintains a high-teens adjusted EBITDA margin.
Envista Holdings Corporation (NYSE: NVST) announced the launch of the Envista Smile Project, a non-profit oral health foundation aimed at improving dental care access for disadvantaged communities. Currently applying for Section 501(c)(3) status, the foundation focuses on collaboration with dental professionals and Envista employees to provide care and education worldwide. CEO Amir Aghdaei emphasized the project's mission of enhancing quality of life through oral health support. This initiative aligns with Envista's broader commitment to dental care innovation and community service.
Envista Holdings Corporation (NYSE: NVST) will announce its second quarter 2021 financial results on August 3, 2021, with a conference call at 2:00 PM PT. The call will feature a discussion of these results and will last approximately one hour. Investors can access the call by dialing 866-342-8588 (U.S.) or +1 203-518-9865 (international), using conference ID #8094612. Webcast materials will be available on Envista's website before the call, with a replay accessible later.
Envista Holdings Corporation (NYSE: NVST) announced its participation in the William Blair 41st Annual Growth Stock Conference on June 1, 2021, at 9:20 AM CT, and the Stifel 2021 Virtual Jaws & Paws Conference on June 2, 2021, at 3:30 PM ET. Investors can access these events through the company's Investor Relations website. Envista, a leader in dental products, supports dental professionals globally with a broad range of solutions aimed to improve patient care and treatment outcomes.
Envista Holdings Corporation (NYSE: NVST) will participate in the Bank of America Healthcare Conference on May 11, 2021, at 11:45 AM ET. Investors can access the event via Envista's Investor Relations website.
As a leading dental products company, Envista offers a comprehensive portfolio that meets about 90% of dentists' clinical needs. The company, which separated from Danaher Corporation in 2019, focuses on continuous improvement and innovation in dental care solutions.
Envista Holdings Corporation (NYSE: NVST) reported a robust Q1 2021 with sales of $709.2 million, a 29.6% increase year-over-year. Core sales rose 29.7%, despite a 3.1% decline from discontinued products. Net income was $71.7 million or $0.41 per diluted share, while adjusted net income reached $95.4 million or $0.54 per diluted share. Adjusted EBITDA surged to $148.0 million compared to $19.4 million in Q1 2020. The CEO expressed optimism about continued growth in the dental market, emphasizing the company's dedication to organic growth and improving operating margins.
Envista Holdings Corporation (NYSE: NVST) has formed a partnership with Curaeos to enhance dental services across the Netherlands, Belgium, Denmark, Germany, and Italy. This collaboration aims to provide innovative dental solutions through Envista's renowned brands such as KaVo and Nobel Biocare, empowering Curaeos' network of clinics to deliver superior patient care. Both companies are committed to improving the patient experience by offering access to training and educational programs through the Curaeos Academy.
Envista Holdings Corporation (NYSE: NVST) will announce its Q1 2021 financial results on May 5, 2021, followed by a conference call at 2:00 PM PT. The call will last approximately an hour and will be accessible through Envista's website. A replay will be available post-presentation. Envista, a prominent player in the dental products sector, offers over 30 brands and addresses about 90% of dentists' needs. The company emphasizes its commitment to innovation and customer focus in delivering quality patient care.
Envista Holdings Corporation (NYSE: NVST) announced a four-year contract extension with Heartland Dental, the largest dental support organization in the U.S. This partnership solidifies Envista's role as a major supplier of dental products such as implants and imaging technology. Since their partnership began in 2016, Heartland Dental has accessed Envista's extensive product portfolio, enhancing care for over 1,800 supported dentists. This extension underscores Envista's commitment to quality and support within the dental industry.
FAQ
What is the current stock price of Envista Holdings (NVST)?
What is the market cap of Envista Holdings (NVST)?
